Chemical inhibitors of the protein 5830415L20Rik can modulate its function through various biochemical pathways. Wortmannin and LY294002 are both inhibitors of phosphoinositide 3-kinases (PI3K), which are involved in a variety of cellular functions such as cell growth, proliferation, and survival. By inhibiting PI3K, these chemicals directly inhibit the downstream signaling pathways that may include 5830415L20Rik, leading to its functional inhibition. Rapamycin, on the other hand, specifically targets and inhibits the mammalian target of rapamycin (mTOR), a crucial regulator of cell growth and proliferation. If 5830415L20Rik is involved in any mTOR-regulated processes, the action of Rapamycin would result in the functional inhibition of this protein.
Further, Staurosporine is a broad-spectrum kinase inhibitor with the capacity to inhibit a multitude of kinases. Since kinases are responsible for phosphorylation, a key post-translational modification that regulates protein activity, Staurosporine can inhibit the function of 5830415L20Rik if it is subject to regulation by phosphorylation. SB203580 and SP600125 are selective inhibitors targeting p38 MAPK and c-Jun N-terminal kinase (JNK) respectively. By inhibiting these kinases, they would inhibit 5830415L20Rik if it is involved in cellular stress response or apoptosis regulated through the p38 MAPK or JNK pathways. Similarly, PD98059 and U0126 target MEK1/2, and if 5830415L20Rik functions within the MAPK/ERK pathway, these inhibitors would suppress its activity. Y-27632, which inhibits the Rho-associated protein kinase (ROCK), would affect 5830415L20Rik if it is involved in pathways regulated by ROCK that control cell shape, motility, and proliferation. ZM-447439, an Aurora kinase inhibitor, would inhibit 5830415L20Rik if it plays a role in cell cycle progression. Lastly, Erlotinib and Sunitinib, which inhibit epidermal growth factor receptor (EGFR) signaling and various receptor tyrosine kinases respectively, would functionally inhibit 5830415L20Rik if it is part of the signaling pathways regulated by these receptors.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a specific inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, downstream signaling pathways that may involve 5830415L20Rik are suppressed, leading to the functional inhibition of the protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 functions similarly to Wortmannin by inhibiting PI3K. This chemical would inhibit the PI3K/Akt signaling pathway, possibly reducing the function of 5830415L20Rik if it is part of this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin binds to and inhibits mTOR, which is involved in cell growth and proliferation. Inhibition of mTOR by Rapamycin could lead to functional inhibition of 5830415L20Rik if it plays a role in mTOR-regulated processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
As a broad-spectrum kinase inhibitor, Staurosporine can inhibit multiple kinases that may be involved in the phosphorylation events necessary for the activity of 5830415L20Rik, thereby inhibiting its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, and by inhibiting p38 MAPK, it could functionally inhibit 5830415L20Rik if the protein is involved in stress response pathways regulated by p38 MAPK. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits the c-Jun N-terminal kinase (JNK) signaling pathway. If 5830415L20Rik is involved in JNK-regulated processes such as inflammation or apoptosis, inhibition of JNK by SP600125 would lead to the functional inhibition of the protein. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is an inhibitor of MEK1/2, upstream of ERK in the MAPK/ERK pathway. Inhibition of MEK1/2 by PD98059 would result in the functional inhibition of 5830415L20Rik if it is linked with the MAPK/ERK pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 also inhibits MEK1/2, and thus ERK pathway activity. If 5830415L20Rik is associated with the ERK pathway, U0126 would functionally inhibit the protein. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 is an inhibitor of Rho-associated protein kinase (ROCK). If 5830415L20Rik is involved in cell motility and proliferation pathways regulated by ROCK, Y-27632 would lead to the functional inhibition of the protein. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
ZM-447439 inhibits Aurora kinase activity. If 5830415L20Rik is a part of cell cycle progression and mitosis that Aurora kinase regulates, this chemical would functionally inhibit the protein. |